Critical Path and Ilex Partner to Deliver Comprehensive Identity and Access Management Suite

* Reuters is not responsible for the content in this press release.

Wed Sep 16, 2009 3:30am EDT

Modular Solutions Address Key Enterprise Management Needs
MACCLESFIELD, England--(Business Wire)--
Critical Path, Inc., a leading provider of messaging applications and enterprise
solutions, today announced its partnership with Ilex and the launch of its
Identity and Access Management Suite. Part of Critical Path`s Memova suite of
applications, the Identity and Access Management Suite enables organizations to
reduce costs, improve operational efficiencies, minimize security risks, enrich
user experiences and streamline compliance. 

The Identity and Access Management Suite addresses three key enterprise
requirements with solutions for:

* Data Management: A high-availability solution that synchronizes and
streamlines the information management processes across an entire organization. 
* Identity and Access Control: An integrated solution that centralizes and
automates secure access to information across the entire enterprise. 
* Business Process Management: A best-of-breed comprehensive process and
workflow solution that enables rapid and easy resolutions to productivity and
operational issues.

Critical Path has a proven history of providing identity management applications
to some of the largest financial institutions, manufacturing and government
bodies in the world including UBS, DHL, Merck, HM Revenue & Customs (Inland
Revenue) and Rolls Royce. The Identity and Access Management Suite now
encompasses integrated workflow and access management capabilities. 

David Longley, VP Northern Europe, Critical Path, comments: "Our collaboration
with Ilex will greatly benefit our mutual customers worldwide. The Identity and
Access Management Suite goes well beyond identity management and encompasses
capabilities like single sign on, provisioning, workflow management, data
integration, security, password management, data management, process management
- all with high availability and robust reporting capabilities. Our modular
approach also means companies can focus on solving key business issues, and then
use the return on that investment to fund the next initiative." 

Stephan Belloni, Product Marketing and Business Development Manager, Ilex adds:
"Partnering with Critical Path is a great opportunity for Ilex and our
customers. The Memova applications are a natural fit with our Meibo and Sign&go
products, resulting in broader, more robust and scalable enterprise solutions.
We look forward to working closely with Critical Path." 

About Critical Path, Inc.

Critical Path`s Memova suite of applications and services are chosen by leading
service providers and enterprises around the world to enable millions of people
to communicate, connect, share and organize while providing industry-leading
safety and assurance. 

With offices around the globe, Critical Path supports companies with their
deployments of Memova solutions to drive revenue, boost loyalty, streamline
operations and reduce costs. More information is available at
www.criticalpath.net. 

About Ilex

Ilex is a software company specializing in IAM (Identity & Access Management).
Its offering in this domain is centered on three solutions: Sign&go (Web SSO,
Enterprise SSO and Federation of identities), Meibo (Workflow, provisioning and
role management) and finally Meibo People Pack (a ready-to-use identity
lifecycle management solution for companies). 

Note to Editors: Critical Path, the Critical Path logo, Messages that Matter,
The World is Mobile, ApplLink, Memova and the Memova logo are the trademarks of
Critical Path, Inc., registered in various jurisdictions. All other trademarks
are the property of their respective holders.





Critical Path, Inc.
Ian Corden, +44 1 625 507 314
pr@criticalpath.net
or
Hotwire
Annette Leach, +44 (0)207 608 2500
criticalpath@hotwirepr.com
or
Ilex
Claire Fauque, +33 (0) 1 46 88 03 47
claire.fauque@ilex.fr

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.